.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Accenture
Citi
Baxter
Express Scripts
Chubb
McKinsey
US Army
Mallinckrodt
Boehringer Ingelheim

Generated: July 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017057

« Back to Dashboard
NDA 017057 describes CYSTO-CONRAY II, which is a drug marketed by Liebel-flarsheim and is included in one NDA. It is available from one supplier. Additional details are available on the CYSTO-CONRAY II profile page.

The generic ingredient in CYSTO-CONRAY II is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.

Summary for NDA: 017057

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 017057

Mechanism of ActionX-Ray Contrast Activity

Suppliers and Packaging for NDA: 017057

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYSTO-CONRAY II
iothalamate meglumine
SOLUTION;INTRAVESICAL 017057 NDA Liebel-Flarsheim Company LLC 0019-0862 0019-0862-07 12 BOTTLE, GLASS in 1 BOX (0019-0862-07) > 250 mL in 1 BOTTLE, GLASS
CYSTO-CONRAY II
iothalamate meglumine
SOLUTION;INTRAVESICAL 017057 NDA Liebel-Flarsheim Company LLC 0019-0862 0019-0862-50 12 BOTTLE, GLASS in 1 BOX (0019-0862-50) > 250 mL in 1 BOTTLE, GLASS

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVESICALStrength17.2%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Deloitte
Daiichi Sankyo
Citi
US Army
Dow
Cantor Fitzgerald
Queensland Health
QuintilesIMS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot